Obama delays lifting of ban on stem cell funding
Advocates are impatient
"As president, I will lift the current administration’s ban on federal funding of research on embryonic stem cell lines created after August 9, 2001 through executive order," wrote Democrat candidate Barack Obama on August 30, 2008. The new president’s promise was clear and advocates for the use of human embryonic stem cells expected him to act quickly. "We are hopeful that removing restrictions on funding for stem cells will be one of the first acts of the Obama presidency," said Harvard’s George Daley shortly after the election.
But nothing has happened. Instead President Obama has signalled that he is waiting for action from Congress. The Coalition for Medical Research, a patient advocacy group, wrote to the President on February 9, pleading with him not to delay. "There is no more time to wait," wrote its president, Amy Comstock Rick. ~ Chicago Tribune, Feb 16
- Queensland legalises ‘assisted dying’ - September 19, 2021
- Is abortion a global public health emergency? - April 11, 2021
- Dutch doctors cleared to euthanise dementia patients who have advance directives - November 22, 2020
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...